Personalised medicine in oncology and the implication for clinical development

• Personalised medicine in oncology: Present & future vision
• Leveraging genomics early for faster, cheaper and more effective molecule development
• Incorporation of biomarkers in the design of pivotal clinical trials: statistical considerations

Moderator

Jamal Gasmi, MD, Ph.D.
VP and Global Lead in Oncology
ICON Clinical Research

Expert Panelists

Alan Phillips, Ph.D.
VP Biostatistics and Programming
ICON Clinical Research
 

Anthony Johnson President/CEO
Empire Genomics